跳至主要内容
临床试验/IRCT20200803048277N1
IRCT20200803048277N1招募中2 期

Evaluation of the Effect of Nervoxin commercial herbal medicine on liver clearance of 99mTc-Sestamibi in human’s myocardial perfusion scan

Mazandaran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • All patients except patients taking drugs that interact with nevroxin, such as digoxin, warfarin, theophylline, etc.
  • All patients except those with known hepatic and renal failure, patients with coagulation problems and heart disease.

排除标准

  • Patients taking drugs that interact with nevroxin, such as digoxin, warfarin, theophylline, etc.
  • People with known hepatic and renal failure, patients with coagulation problems and heart patients

研究者

相似试验